Two pharmaceutical giants, GSK and Amgen, are partnering with the Trump administration's prescription drug platform called TrumpRX. The announcement was reported by Fox Business on Friday.

Two major pharmaceutical companies will be partnering with the Trump administration’s prescription drug platform, according to a Friday report from Fox Business.
GSK and Amgen have agreed to include their medications on TrumpRX, the prescription drug platform created by President Donald Trump’s administration. The move represents a significant expansion of the government’s prescription drug initiative.
The announcement comes as the administration continues efforts to address prescription drug costs and accessibility for American consumers.
Virginia Boater Files Lawsuit Over Massive Potomac River Sewage Spill
Former Nixon Aide Who Exposed Watergate Tapes Dies at 99
Texas Mariachi Teen Musicians Detained by ICE Draw Political Support
Kentucky Soldier Dies from Injuries in Iran Conflict, Becomes 7th U.S. Casualty